These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16061931)

  • 1. Regulation of body weight by proopiomelanocortin peptides in humans: lessons from the Nelson syndrome.
    Sekhar RV; Goodman JC; Balasubramanyam A; Tatro JB; Mihaly E
    Ann Intern Med; 2005 Aug; 143(3):238-9. PubMed ID: 16061931
    [No Abstract]   [Full Text] [Related]  

  • 2. Nelson's syndrome: one disease or two?
    Salcman M; Garcia JH; Abbott JD; Martin LG
    Neurosurgery; 1979 Oct; 5(4):480-4. PubMed ID: 230424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of N-terminal (1-76) of human proopiomelanocortin in human plasma: correlation with adrenocorticotropin.
    Chan JS; Seidah NG; Chrétien M
    J Clin Endocrinol Metab; 1983 Apr; 56(4):791-6. PubMed ID: 6300165
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.
    Lamberts SW; Klijn JG; de Quijada M; Timmermans HA; Uitterlinden P; de Jong FH; Birkenhäger JC
    J Clin Endocrinol Metab; 1980 Aug; 51(2):307-11. PubMed ID: 6249835
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of Nelson's syndrome by octreotide: a case report.
    Petrini L; Gasperi M; Pilosu R; Marcello A; Martino E
    J Endocrinol Invest; 1994 Feb; 17(2):135-9. PubMed ID: 8006335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.
    Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
    Horm Metab Res; 1984 Feb; 16(2):107-8. PubMed ID: 6323292
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of indomethacin to suppress plasma adrenocorticotropin levels and beta-endorphin-like immunoreactivity in Nelson's syndrome.
    Kasperlik-Załuska A; Jeske W; Migdalska B; Jastrzebska H
    Endokrynol Pol; 1987; 38(3):243-6. PubMed ID: 2836186
    [No Abstract]   [Full Text] [Related]  

  • 9. Two unusual variants of Nelson's syndrome.
    Bonner RA; Mukai K; Oppenheimer JH
    J Clin Endocrinol Metab; 1979 Jul; 49(1):23-9. PubMed ID: 221528
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
    Kasperlik-Załuska A; Drac-Kaniewska J; Migdalska B; Jeske W; Wiśniewska-Woźniak T
    Endokrynol Pol; 1988; 39(5):245-52. PubMed ID: 2855625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of two-site immunoradiometric method for direct analysis of ACTH in human plasma].
    Jeske W; Kasperlik-Załuska A; Słowińska-Srzednicka J; Soszyński P; Rogoziński W
    Endokrynol Pol; 1988; 39(2):75-82. PubMed ID: 2852100
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation and association between calcitonin and adrenocorticotropin secretion.
    Lamberts SW; Hackeng WH; Visser TJ
    J Clin Endocrinol Metab; 1980 Mar; 50(3):565-8. PubMed ID: 6244325
    [No Abstract]   [Full Text] [Related]  

  • 13. The evaluation of sodium valproate in the treatment of Nelson's syndrome.
    Dornhorst A; Jenkins JS; Lamberts SW; Abraham RR; Wynn V; Beckford U; Gillham B; Jones MT
    J Clin Endocrinol Metab; 1983 May; 56(5):985-91. PubMed ID: 6300181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment.
    Aronin N; Krieger DT
    N Engl J Med; 1980 Feb; 302(8):453-5. PubMed ID: 6243392
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of nivazol in Nelson's syndrome.
    Ball JA; Williams G; Yeo TH; Joplin GF
    Postgrad Med J; 1988 Mar; 64(749):220-1. PubMed ID: 2845380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human plasma ACTH, lipotropin, and endorphin.
    Krieger DT; Yamaguchi H; Liotta AS
    Adv Biochem Psychopharmacol; 1981; 28():541-56. PubMed ID: 6259909
    [No Abstract]   [Full Text] [Related]  

  • 17. [beta-endorphin secretion and its clinical significance in a patient with Nelson's syndrome (author's transl)].
    Oki S; Nakao K; Nakai Y; Imura H
    Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):458-66. PubMed ID: 6286812
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of octreotide in a patient with Nelson's syndrome.
    Kelestimur F; Utas C; Ozbakir O; Selçuklu A; Kandemir O; Ozcan N
    Postgrad Med J; 1996 Jan; 72(843):53-4. PubMed ID: 8746287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma knife stereotactic radiosurgery of Nelson syndrome.
    Vik-Mo EO; Øksnes M; Pedersen PH; Wentzel-Larsen T; Rødahl E; Thorsen F; Schreiner T; Aanderud S; Lund-Johansen M
    Eur J Endocrinol; 2009 Feb; 160(2):143-8. PubMed ID: 18996962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of aminoglutethimide on ACTH plasma levels in Cushing's disease and Nelson syndrome].
    Kasperlik-Załuska AA; Migdalska B; Jeske W; Niegowska E; Wiśniewska-Woźniak T
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1006-8. PubMed ID: 1339054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.